Pharma and healthcare: sector news on Monday 9 November 2026
Average tone +0.3 (neutral) across 5 companies with relevant coverage, from 12 stories.
How to read a score. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Company by company
| Company | Tone | Stories | What the coverage was about |
|---|---|---|---|
| AstraZeneca | +5.3 | 4 | Coverage centred on AstraZeneca's $10 billion Rhythm acquisition, seen as a push into rare obesity and metabolic disease. |
| GSK | −3.3 | 3 | Coverage was dominated by the planned closure of a German vaccine plant with 641 jobs at risk, which leans negative. |
| Convatec | +0.5 | 2 | |
| Haleon | −1.7 | 2 | Coverage was mixed: one piece points to a higher annual net income, while another describes a slowdown and tougher outlook. |
| Smith & Nephew | +0.8 | 1 | The only relevant coverage was a summary of the company's third-quarter earnings call, which gives little clear direction either way. |
Strongest stories in the sector
- −8.3 Describes slower recent quarter and a more difficult outlook.}
- −7.5 Plant closure puts hundreds of jobs at risk, reflecting restructuring.
- +7.5 Reports a sizeable annual rise in profit for the company.}
- +6.7 Nine-month growth noted ahead of investor meetings.
- +5.0 Large acquisition expands its presence in rare obesity treatment.
- +4.2 Analysis of strategic move into rare metabolic disease via Rhythm purchase.
- +3.3 Awareness campaign aimed at improving cancer testing uptake.
- +2.5 GSK engaged with Indonesian regulator on health science and innovation.
- +0.8 Upcoming investor conference appearances, mostly routine scheduling.
- +0.8 Summary of the company's quarterly investor call; tone not clearly positive or negative.
- +0.5 x
Pharma and healthcare: every day · FTSE 100 overview for the day
Follow by email
A short, free morning email on how the news treated the Pharma and healthcare sector: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.